Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SYK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 3.476B
March 31, 2026 2.965B
December 31, 2025 4.10B
September 30, 2025 3.343B
June 30, 2025 2.464B
March 31, 2025 2.409B
December 31, 2024 4.493B
September 30, 2024 4.684B
June 30, 2024 1.957B
March 31, 2024 2.407B
December 31, 2023 3.053B
September 30, 2023 1.936B
June 30, 2023 1.478B
March 31, 2023 1.757B
December 31, 2022 1.928B
September 30, 2022 1.497B
June 30, 2022 1.127B
March 31, 2022 1.53B
December 31, 2021 3.019B
September 30, 2021 2.639B
June 30, 2021 2.325B
March 31, 2021 2.312B
December 31, 2020 3.024B
September 30, 2020 7.161B
June 30, 2020 6.619B
Date Value
March 31, 2020 4.048B
December 31, 2019 4.425B
September 30, 2019 2.036B
June 30, 2019 1.839B
March 31, 2019 1.758B
December 31, 2018 3.699B
September 30, 2018 2.21B
June 30, 2018 1.92B
March 31, 2018 2.455B
December 31, 2017 2.793B
September 30, 2017 2.689B
June 30, 2017 3.747B
March 31, 2017 3.279B
December 31, 2016 3.384B
September 30, 2016 3.022B
June 30, 2016 3.656B
March 31, 2016 7.483B
December 31, 2015 4.079B
September 30, 2015 3.372B
June 30, 2015 4.277B
March 31, 2015 4.263B
December 31, 2014 5.00B
September 30, 2014 4.677B
June 30, 2014 4.745B
March 31, 2014 4.047B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 5.246B
Zimmer Biomet Holdings, Inc. 410.00M
Edwards Lifesciences Corp. 4.255B
Abbott Laboratories 5.603B
Becton, Dickinson & Co. 864.00M